References
- Kostakoglu L, Hardoff R, Mirtcheva R, et al. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 2004;24(5):1411-31 https://doi.org/10.1148/rg.245035725
- Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scaning: potential for error in interpretation. Semin Nucl Med 1996;26:308-14 https://doi.org/10.1016/S0001-2998(96)80006-7
- Israel O, Yetremor N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005;46:758-62
- Kresnik E, Gallowitsch HJ, Mikosch P, et al. (18)F-FDG positron emission tomography in the early diagnosis of enterocolitis: preliminary results. Eur J Nucl Med Mol Imaging 2002;29:1389- 92 https://doi.org/10.1007/s00259-002-0901-7
- Israel O, Mor M, Guralnik L, et al. The New Technology of Combined Transmission and Emission F-18 FDG Tomography (FDG-TET) in the Diagnosis and Management of Cancer Patients. Clin Positron Imaging 2000;3:143 https://doi.org/10.1016/S1095-0397(00)00055-8
- Schiepers C, Hoh CK. Positron emission tomography as a diagnostic tool in oncology. Eur Radiol 1998;8:1481-94 https://doi.org/10.1007/s003300050579
- Yun M, Choi HS, Yoo EH, Bong JK, Ryu YH, Lee JD. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7
- Yasuda S, Fujii H, Nakahara T, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med 2001;42:989-92
- Kim TH, Park SH, Oh HS, et al. A case of colorectal villous adenoma found with PET-CT. Korean J Gastrointest Endosc 2005;31:263-7
-
Stahl A, Ott K, Weber WA, et al. FDG-PET imaging of locally advanced gastric carcinomas:corrlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003: 30:288-95
https://doi.org/10.1007/s00259-002-1029-5 - Chae MJ, Cheon GJ, Lee SW, et al. Patterns of FDG uptake in Stomach on F-18 FDG Positron Emission Tomography: Correlation with Endoscopic findings. korean J Nucl Med 2005;39(6):456-63
- Tan LT, Ong KL. Semi-quantitative measurement of normal organs with variable metabolic activity on FDG PET imaging. Ann Acad Med Singapore 2004;33:183-5
- Salaun PY, Grewal RK, Dodamane I, Yeung HW, Larson SM, Strauss HW. An analysis of the 18F-FDG uptake pattern in the stomach. J Nucl Med 2005;46:48-51
- Lee HJ, Yun M, Ko D, Ryu YH, Lee JD. Use of hydro-FDG PET in the detection of primary tumors of the stomach. J Nucl Med 2005(abstr):424p
- Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel Hot Spots at PET-CT. Radiographics 2007;27:145-59 https://doi.org/10.1148/rg.271065080
- Raking GR, Price PM. Positron emission tomographic imaging of angiogenesis and vascular function. Br J Radiol 2003;76(suppl): 50S-9S https://doi.org/10.1259/bjr/30399077
- Bergmann R, Pietzsch J, Fuechtner F, et al. 3-O-methyl-6 -18F-fluoro-L-dopa, a new tumor imaging agent: investigation of transport mechanism in vitro. J Nucl Med 2004;45:2116-22
- Wells P, West C, Jones T, Harris A, Price P. Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[11C]-thymidine. Biochim Biophys Acta 2004;1705:91-102